Search clinical trials for: duloxetine

Total 639 results

Torrent Pharmaceuticals Limited

Completed

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Fluoxetine Tablet Under Fasting Conditions

Healthy Subjects
University of Texas Southwestern Medical Center
National Institute of Mental Health (NIMH)

Completed

Cognitive Behavioral Therapy for Depression Relapse Prevention in Children and Adolescents

Depression

United States
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules 90 mg of Dr. Reddy's Under Fed Condition

Healthy

India
Fondo Nacional de Desarrollo Científico y Tecnológico...

Completed

A Randomized Clinical Trial for Depressed Mothers at Primary Care Level (DMH)

Depression

Chile
University Health Network, Toronto
Sunnybrook Health Sciences Centre; University of British Columbia; University... and other collaborators

Completed

Fluoxetine Opens Window to Improve Motor Recovery After Stroke (FLOW)

Vascular Diseases | Stroke | Cerebrovascular Disorders | Brain Diseases | Central Nervous System Diseases | Nervous System Diseases | Brain Ischemia | Cerebral Infarction | Brain Infarction | Cerebrovascular Accident

Canada
Otsuka Pharmaceutical Development & Commercialization...

Completed

A Phase 1, Drug Interaction Study Between AVP-786 and Paroxetine and Between AVP-786 and Duloxetine in Healthy Subjects

Drug-drug Interaction

Australia
New York State Psychiatric Institute
National Institute on Aging (NIA)

Completed

Treating Hearing Loss to Improve Mood and Cognition in Older Adults

Depression | Hearing Loss

United States
Janssen Research & Development, LLC

Completed

A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant Depression (SUSTAIN-1)

Depressive Disorder, Treatment-Resistant

United States, France, Poland, Belgium, Germany, Spain, Mexico, Turkey, Canada, Brazil, Estonia, Hungary, Slovakia, Sweden, Czechia
Takeda

Completed

Efficacy of Lu AA21004 on Cognitive Dysfunction in Major Depressive Disorder

Depressive Disorder, Major

United States, Ukraine, Germany, Poland, Bulgaria, Finland, Russian Federation
H. Lundbeck A/S

Completed

Randomised Placebo-controlled Duloxetine-referenced Study of Efficacy and Safety of 5 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Elderly Patients

Major Depressive Disorder
Takeda

Completed

Safety and Efficacy of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder

Depressive Disorder, Major

United States
Takeda
H. Lundbeck A/S

Completed

Efficacy and Safety of Vortioxetine (Lu AA21004) in the Treatment of Patients With Major Depressive Disorder

Major Depressive Disorder

United States
Turku University Hospital
University of Helsinki

Withdrawn

Efficacy, Safety, Tolerability and Pharmacokinetics of Concomitant Administration of Tramadol With Duloxetine or Pregabalin

Diabetic Polyneuropathy | Postherpetic Neuralgia

Finland
University of Pittsburgh
National Institute of Mental Health (NIMH)

Completed

Antidepressant Medication Plus Donepezil for Treating Late-life Depression

Depression | Dementia

United States
SK Chemicals Co., Ltd.

Completed

Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 50mg

Drug Interaction Potentiation
Tanta University

Recruiting

Comparative Clinical Study Evaluating the Possible Efficacy of Duloxetine, Gabapentin and Lacosamide on Oxaliplatin-Induced Peripheral Neuropathy in Cancer Patients

Oncology

Egypt
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Participants With Treatment-resistant Depression (TRANSFORM-3)

Depressive Disorder, Treatment-Resistant

United States, France, Belgium, Spain, Poland, Bulgaria, South Africa, Finland, Brazil, Sweden, United Kingdom, Lithuania
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression (TRANSFORM-2)

Treatment-resistant Depression

United States, Poland, Germany, Spain, Czechia
Mark Ware

Terminated

Genetic Variants Associated With Low Back Pain and Their Response to Treatment With Duloxetine or Propranolol

Low Back Pain

Canada
Aarhus University Hospital
University of Aarhus; Central Denmark Region; Vejle Hospital; TrygFonden, Denmark; Aalborg University Hospital and other collaborators

Recruiting

Patient Education and Duloxetine, Alone and in Combination, for Patients With Multisystem Functional Somatic Disorder (EDULOX)

Functional Disorder

Denmark
Rambam Health Care Campus

Completed

Biomarkers for Prediction of Analgesic Efficacy in Knee OA.

Knee, Osteoarthritis (OA) | Biomarkers for Prediction of OA Treatment Efficacy

Israel
St George's, University of London
Rosetrees Trust

Completed

Pain Management in Osteoarthritis Using the Centrally Acting Analgesics Duloxetine and Pregabalin (DUPRO)

Hand Osteoarthritis

United Kingdom
Eli Lilly and Company

Completed

A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing

Major Depressive Disorder

Japan
Mayo Clinic
University of Minnesota; Thorne Research Inc.

Completed

Use of 31P MRS to Assess Brain NAD+ in Healthy Current and Former Collegiate Athletes (TRMC-004)

Concussion, Mild

United States
Torrent Pharmaceuticals Limited

Completed

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Fluoxetine Tablets Under Fed Conditions

Healthy Subjects
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules, 90 mg of Dr. Reddy's Under Fasting Condition

Healthy

India
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Efficacy, Pharmacokinetics, Safety and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression

Depressive Disorder, Treatment-Resistant

United States, China
Yuqi Cheng

Unknown

A Prediction Study of Multiple Indexes of the Effect of Different Mechanisms of Antidepressants Treatment on Depression

Major Depressive Disorder | Depression, Unipolar

China
H. Lundbeck A/S

Completed

Randomised Placebo-controlled Duloxetine-referenced Efficacy and Safety Study of 2.5, 5 and 10 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder

Major Depressive Disorder
St. Joseph's Healthcare Hamilton

Unknown

Electroencephalography (EEG) Signal Processing (EEG-SP)

Major Depressive Disorder

Canada
Eli Lilly and Company
Boehringer Ingelheim

Completed

An Open-Label Comparison of Duloxetine to Other Alternatives for the Management of Diabetic Peripheral Neuropathic Pain

Diabetic Neuropathy, Painful

Germany, United States
Pfizer

Completed

Non-interventional, Retrospective Cohort Study to Explore Antidepressant Treatment in Korea

Major Depression

Korea, Republic of
Eli Lilly and Company

Completed

A Study of LY110140 in Healthy Japanese Male Participants

Healthy Volunteer

Japan
University of Bern
Swiss National Science Foundation; University of Zimbabwe

Not yet recruiting

The Friendship Bench Plus Trial (FB+)

Major Depressive Disorder | Severe Depressive Episode Without Psychotic Symptoms

Zimbabwe
U.S. Army Medical Research and Development Command
PPD; Idorsia Pharmaceuticals Ltd.; Berry Consultants; Cambridge Cognition Ltd; Ci...

Recruiting

Department of Defense PTSD Adaptive Platform Trial Intervention A - Fluoxetine

Post Traumatic Stress Disorder

United States
Harvard Medical School (HMS and HSDM)
Sangath; National Institute of Mental Health (NIMH); Massachusetts General Hospital and other collaborators

Recruiting

Improving Outcomes in Depression in Primary Care in a Low Resource Setting (OptimizeD)

Depressive Disorder | Depression

India
CAR-T (Shanghai) Biotechnology Co., Ltd.

Not yet recruiting

Clinical Study on the Safety and Efficacy of Dental Pulp Mesenchymal Cells in the Treatment of Depression

Depression
Future University in Egypt

Completed

Bioequivalence Study of Fluoxetine in Healthy Adult Subjects Under Fasting Condition

Healthy Subjects

Egypt
Massachusetts General Hospital
Muhimbili University of Health and Allied Sciences

Completed

Measuring Ambulation, Motor, and Behavioral Outcomes With Post-Stroke Fluoxetine in Tanzania (MAMBO)

Stroke, Ischemic | Acute Stroke

Tanzania
Assistance Publique - Hôpitaux de Paris

Withdrawn

Fluoxetine Essay in Children With Autism (FAIR)

Autism
Johns Hopkins University
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Recruiting

A Sequenced Strategy for Improving Outcomes in People With Knee Osteoarthritis Pain (SKOAP)

Knee Osteoarthritis

United States
Boston Medical Center

Withdrawn

Duloxetine Tibial Plateau

Pain, Postoperative | Tibial Plateau Fracture

United States
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression (TRANSFORM-1)

Treatment-resistant Depression

United States, France, Belgium, Mexico, Canada, Brazil, Estonia, Hungary, Slovakia
The Scripps Research Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Duloxetine Versus Pregabalin for Alcohol Dependence

Alcohol Dependence

United States
H. Lundbeck A/S

Completed

Randomised Placebo-controlled Duloxetine-referenced Study of Efficacy and Safety of 15 and 20 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Adults

Major Depressive Disorder
Takeda
H. Lundbeck A/S

Completed

Efficacy of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder

Generalized Anxiety Disorder

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Concomitant Use of PriLigy in Men Treated for Erectile Dysfunction (COUPLE)

Sexual Dysfunction | Erectile Dysfunction

France, Poland, United States, Belgium, Mexico, Malaysia, Canada, Taiwan, Korea, Republic of, Russian Federation, Argentina, Australia, United Kingdom
Moises Domingo
Dr. Alejandro Molina Cabeza; Susana Ferrandis Martinez

Completed

Brain Networks Implicated in Lifelong Premature Ejaculation Patients (LPE)

Sexual Dysfunction | Premature Ejaculation

Spain
Jinling Hospital, China

Unknown

Tissue Kallikrein Preventing the Restenosis After Stenting of Symptomatic MCA Atherosclerotic Stenosis

Cerebrovascular Disease

China
Xijing Hospital of Digestive Diseases

Recruiting

Predicting Treatment Outcomes in Refractory Constipation Through Brain Connectivity Evaluation

Brain Connectivity | Constipation - Functional | fMRI | Treatment Efficacy | Fluoxetine | Somatic Symptom | Refractory Constipation | Mental Symptom

China

Search clinical trials for: duloxetine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Suriname

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations